Enterprise Value
760.8M
Cash
204.4M
Avg Qtr Burn
-52.64M
Short % of Float
0.01%
Insider Ownership
0.00%
Institutional Own.
0.58%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
PDUFA Approval decision | ||
VLA15 Details Bacterial infection, Lyme disease | Phase 3 Data readout | |
VLA2001 Details Infectious disease, COVID-19 | Failed Discontinued |